During the past decade, Henry Ford Health System Irb conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Henry Ford Health System Irb" are "Hepatitis B" (1 trials), "Liver Cancer" (1 trials) and "Multiple Myeloma" (1 trials). Many other conditions were trialed in "Henry Ford Health System Irb" in a lesser frequency.

Most popular intervention types in "Henry Ford Health System Irb" are "Drug" (3 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Adefovir (ADV)" (1 trials), "Best Supportive Care" (1 trials), "Bortezomib" (1 trials), "Brivanib" (1 trials) and "Entecavir (ETV)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Henry Ford Health System Irb" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Henry Ford Health System Irb". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Henry Ford Health System Irb, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Henry Ford Health System Irb, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".